As said by others, the only reason I personally see for tomorrow's news being "bad" is if you're betting on shorting the stock. Most people who see the long term value of this stock would only see Wednesday as mainly positive, no matter what the news pretty much; unless it was an FDA hold or AE. But even increasing the shares, even with a discount, means that longs can add to their position at lower prices, and even lower their average entry... Because as things continue to progress with the drug itself in such positive PRs, the long term for this stock is excellent in my opinion.
No offense, but those whining about 1-2 years need to realize how many drugs fail to make it to market. One only needs to read about Arrowhead, Juno, and others to see that. If Pro-140 continues to perform, I believe many will be giddy when they say they entered the stock at $1.50. I'm in at $1.17, and looking to add more.
Good luck to all.
News 
Market Data 
Discover 
AI
